Entrada Therapeutics (TRDA) Reports Q1 Net Loss of $21.7M

Go back to Entrada Therapeutics (TRDA) Reports Q1 Net Loss of $21.7M
(NASDAQ: TRDA) Delayed: 7.46 +0.01 (0.13%)
Previous Close $7.45    52 Week High
Open $7.45    52 Week Low
Day High $7.53    P/E N/A 
Day Low $7.21    EPS
Volume 237,986